The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients

Neoplasma

Volumn 56, Issue 2, 2009, Pages 114-118

  Cao, Z ^a,b   Song, J H ^a   Park, Y K ^a   Maeng, E J ^a   Nam, S W ^a   Lee, J Y ^a   Park, W S ^a  

^a The Catholic University of Korea   (South Korea)

^b Binzhou Medical Collage   (China)

Author keywords

Colorectal cancer; Metastasis; p53; Polymorphism; Susceptibility

Indexed keywords

ARGININE; PROTEIN P53; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; COLORECTAL CANCER; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GROWTH DISORDER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAJOR GENE; MALE; NORTH KOREA; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CODON; COLORECTAL NEOPLASMS; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 65649100143     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_02_114     Document Type: Article

References (27)

1. Shin MH, Oh HK, Ahn YO. Ten year trend of cancer incidence in seoul, Korea: 1993-2002. J Prev Med Pub Health 2008; 41: 92-99. doi:10.3961/jpmph.2008. 41.2.92 PMid:18385549
2. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767. doi:10.1016/0092-8674(90)90186-I PMid:2188735
4. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-310. doi:10.1038/35042675 PMid:11099028
5. Thomas M, Kalita A, Labrecque S et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19: 1092-1100. (Pubitemid 29046852)
6. Bergamaschi D, Samuels Y, Sullivan A et al. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 2006; 38: 1133-1141. doi:10.1038/ng1879 PMid:16964264 (Pubitemid 44470358)
7. Dumont P, Leu JI, Della Pietra AC 3rd et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 2003; 33: 357-365. doi:10.1038/ng1093 PMid:12567188
8. Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 2004; 108: 196-199. doi:10.1002/ijc.11548 (Pubitemid 37541770)
9. Sjalander A, Birgander R, Athlin L et al. p53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis 1995; 16: 1461-1464. doi:10.1093/ carcin/16.7.1461 PMid:7614678
10. Zhu ZZ, Wang AZ, Jia HR et al. Association of the TP53 Codon 72 Polymorphism with Colorectal Cancer in a Chinese Population. Jpn J Clin Oncol 2007; 37: 385-390. doi:10.1093/ jjco/hym034 PMid:17599946 (Pubitemid 47248959)
11. Gemignani F, Moreno V, Landi S et al. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene 2004; 23: 1954-1956. doi:10.1038/sj.onc.1207305 PMid:14647431 (Pubitemid 38445422)
12. Koushik A, Tranah GJ, Ma J et al. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer 2006; 119: 1863-1868. doi:10.1002/ijc.22057 (Pubitemid 44356844)
13. Murata M, Tagawa M, Kimura M et al. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 1996; 17: 261-264. doi:10.1093/carcin/17.2.261 PMid:8625447 (Pubitemid 26091303)
14. Sayhan N, Yazici H, Budak M et al. p53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection. Res Commun Mol Pathol Pharmacol 2001; 109: 25-34.
15. Olschwang S, Laurent-Puig P, Vassal A et al. Characterization of a frequent polymorphism in the coding sequence of the Tp53 gene in colonic cancer patients and a control population. Hum Genet 1991; 86: 369-370. doi:10.1007/BF00201836 PMid:1999338
16. Lung FW, Lee TM, Shu BC et al. p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan. J Cancer Res Clin Oncol 2004; 130: 728-732. doi:10.1007/ s00432-004-0605-614 PMid:15365822
17. Beckman G, Birgander R, Sjalander A et al. Is p53 polymorphism maintained by natural selection? Hum Hered 1994; 44: 266-270. doi:10.1159/000154228 PMid:7927355
18. Lee JY, Dong SM, Kim SY et al. A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections. Virchows Arch 1998; 433: 305-309. doi:10.1007/s004280050253 PMid:9808431
19. Burns T F, El-Deiry W S. The p53 pathway and apoptosis. J Cell Physiol 1999; 181: 231-239. doi:10.1002/ (SICI)1097-4652(199911)181:2〈231::AID- JCP5〉3.0.CO;2-L PMid:10497302
20. Walker K K, Levine A J. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 1996; 93: 15335-15340. doi:10.1073/ pnas.93.26.15335
21. Sakamuro D, Sabbatini P, White E et al. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 1997; 15: 887-888. doi:10.1038/ sj.onc.1201263 PMid:9285684 (Pubitemid 27399550)
22. Koushik A, Platt RW, Franco EL. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 2004; 13: 11-22. doi:10.1158/1055-9965.EPI-083-3 (Pubitemid 38116615)
23. Jee SH, Won SY, Yun JE et al. Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis. Int J Gynaecol Obstet 2004;85:301-308. doi:10.1016/j.ijgo.2003.08.017 (Pubitemid 38622573)
24. Matakidou A, Eisen T, Houlston RS. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 2003; 18: 377-385. doi:10.1093/mutage/geg008 PMid:12840112 (Pubitemid 36850206)
25. Perez LO, Abba MC, Dulout FN et al. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol 2006; 12: 1426-1429.
26. Hadhri-Guiga B, Toumi N, Khabir A et al. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia. Cancer Genet Cytogenet 2007; 178: 89-93. doi:10.1016/j.cancergencyto.2007.05.013 PMid:17954263 (Pubitemid 47595352)
27. Wang A, Zhu Z, Cong W et al. Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2008; 25: 168-171. (Pubitemid 351548542)